An interventional study of Take your sexuality back in Posttraumatic Stress Symptoms, Sexual Abuse and Sexual Trauma, sponsored by Sykehuset Telemark. Not yet recruiting at 1 site in Norway. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-09-08.
Sponsored by Sykehuset Telemark · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
This study looks at the potential effects of a new group treatment called "Take Your Sexuality Back", designed for women who have experienced sexual trauma. Investigators will collect information in two ways-through forms that participants fill out themselves and through ECG measurements during a stress tests. Data will be collected before the treatment, right after it, and again three months later. When all data are collected and analyzed investigators will carry out in-depth interviews with participants and explore how they felt about being tested and how they understand the results -especially if some numbers look unusual or surprising. The goal with this study is to create a strong foundation for a future larger-scale study of the treatment by testing the methods, estimating the size of possible effects and identify outcome measurements that are experienced as meaningful to the participants.
14 studies on the registry are indexed under Sexual Trauma; 6 are open to participants now.
This study's planned enrollment of 20 is below the median of 26 across 12 interventional studies indexed under Sexual Trauma.
Browse Sexual Trauma studies →Sykehuset Telemark is the lead sponsor of 33 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A 12 week group intervention
Behavioral: Take your sexuality back
A 12 weeks group program.
PTSD-symptoms and complex PTSD symptoms
The international trauma questionnaire (ITQ). Zero (0) is equivalent to nothing and 4 indicates extremely. Higher scores mean worse outcome.
Time frame: From enrollment to 3 month after end of treatment (12 weeks treatment)
Sexual satisfaction
The Sexual Satisfaction Scale for women (SSS-W). Different Likert scales. Higher scores mean worse outcome. Higher scores mean better outcome.
Time frame: From enrollment to 3 months after end of treatment (12 weeks intervention)
Sexual shame
The Sexual shame index-revised (SSI-R). One (1) is equivalent to strongly disagree and 6 indicates strongly agree. Higher scores mean worse outcome.
Time frame: From enrollment to 3 months after end of treatment (12 weeks intervention).
Interoceptive awareness
The Multidimensional Assessment of Interoceptive Awareness (MAYA 2). Zero is equivalent with never and 5 indicates always. Higher scores mean better outcome.
Time frame: From enrollment to 3 months after end of treatment (12 weeks intervention).
Responses to script-driven imagery.
The Responses to script-driven imagery (RSDI) measures emotional, cognitive, and physiological responses in the script-driven imagery procedure. Zero is equivalent to "not at all" and six (6) indicates "very much". Higher scores mean worse outcome.
Time frame: From enrollment to 3 months after end of treatment (12 weeks intervention).
Touch body map
Touch Body Map is an instrument for mapping how the body reacts to touch. Participants color the outlines of a human figure with three colors to mark how different areas of the body react to touch form a loved one. The body map gives a non-verbal expression of how trauma is embodied. The percentage of the different colors will be calculated to assess possible changes through the process
Time frame: From enrollment to 3 months after end of the treatment (12 weeks intervention).
Change in HRV and SampEn from pre-post and at follow up efter 3 month.
Cardiovascular measurement (ECG) recorded during a script-driven imagery (SDI). HRV and SampEn.
Time frame: Enrollment to 3 months after end of treatment (12 weeks intervention).
Participants experiences of being tested and their understanding of the results.
In-depth interviews with focus on participants own experiences and understanding og the quantitative results.
Time frame: Three month after end of treatment, when all quantitative results are analyzed and calculated.
Plan to share: No — Data are sensitive and participants' anonymity cannot be guaranteed.
Start is estimated for Sep 2025; primary completion for Sep 2026, 12 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sykehuset Telemark